IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) Chairman Todd Hannigan acquired 300,000 shares of the stock in a transaction on Monday, July 13th. The stock was bought at an average cost of $3.59 per share, for a total transaction of $1,077,000.00. Following the transaction, the chairman owned 26,633,334 shares of the company’s stock, valued at approximately $95,613,669.06. This trade represents a 1.14% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.
Todd Hannigan also recently made the following trade(s):
- On Friday, July 10th, Todd Hannigan bought 225,000 shares of IperionX stock. The shares were bought at an average cost of $3.58 per share, with a total value of $805,500.00.
- On Tuesday, April 28th, Todd Hannigan purchased 220,000 shares of IperionX stock. The shares were bought at an average price of $4.48 per share, with a total value of $985,600.00.
- On Wednesday, April 29th, Todd Hannigan purchased 260,000 shares of IperionX stock. The shares were bought at an average price of $4.20 per share, with a total value of $1,092,000.00.
IperionX Stock Performance
NASDAQ:IPX opened at $25.03 on Monday. IperionX Limited Sponsored ADR has a 12 month low of $21.66 and a 12 month high of $61.45. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03. The firm’s 50 day moving average is $34.28 and its 200 day moving average is $37.50.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on IPX. Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a research note on Tuesday, April 21st. BTIG Research lifted their price objective on IperionX from $40.00 to $55.00 and gave the stock a “buy” rating in a report on Friday, June 5th. Alliance Global Partners restated a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. Finally, Roth Capital reaffirmed a “buy” rating on shares of IperionX in a report on Monday, June 8th. Five equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $60.33.
Get Our Latest Report on IperionX
About IperionX
IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of highâpurity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.
At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.
Further Reading
- Five stocks we like better than IperionX
- 3 Overlooked Stocks Positioned for the Next Market Rotation
- 3 Non-Tech Stocks Still Winning Big on AI
- Achieve Robust Diversification With These 3 Equal-Weight ETFs
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
